Factor XIa Inhibitors as New Anticoagulants-Reference-Cited by-同舟云学术

Factor XIa Inhibitors as New Anticoagulants

Published:2018-05-18 Issue:17 Volume:61 Page:7425-7447
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Quan Mimi L.¹^ORCID,Pinto Donald J. P.¹^ORCID,Smallheer Joanne M.¹,Ewing William R.¹,Rossi Karen A.¹,Luettgen Joseph M.¹,Seiffert Dietmar A.¹,Wexler Ruth R.¹

Affiliation:

1. Research and Development, Bristol-Myers Squibb Company, P.O. Box 5400, Princeton, New Jersey 08543, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b00173

Reference87 articles.

1. Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association

2. Overview of the New Oral Anticoagulants

3. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

4. Review article: Coagulation cascade and therapeutics update: Relevance to nephrology. Part 1: Overview of coagulation, thrombophilias and history of anticoagulants

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in covalent drug discovery: a 2020–23 patent landscape analysis focused on select covalent reacting groups (CRGs) found in FDA-approved drugs;Expert Opinion on Therapeutic Patents;2024-09-11

2. Crystal structure of (S)-4-(2-(4-(2-acetyl-5-chlorophenyl)-3-methoxy-6-oxopyridazin-1(6H)-yl)-3-phenylpropanamido)benzoic acid monohydrate, C₂₉H₂₆ClN₃O₇;Zeitschrift für Kristallographie - New Crystal Structures;2024-07-31

3. Safety, tolerability, pharmacokinetics and pharmacodynamics of milvexian with aspirin and/or clopidogrel in healthy participants;Scientific Reports;2024-07-18

4. Milvexian: A Focus on a New Oral Anticoagulant that Targets Factor XIa for Thromboembolism Prophylaxis;Cardiology in Review;2024-02-02

5. Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes;Stroke;2024-02